Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.
Clinical trial NCT02058901 · COMPLETED
Trial details
- NCT number
- NCT02058901
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2019-06-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.